Inhalation delivery of liposomal drugs has distinct advantages for the treatment of pulmonary diseases. Inhalable liposomes of several drugs are currently undergoing clinical trials for a range of indications in the lungs. Herein, general principles of pulmonary delivery as well as the clinical development of inhalable liposomal drugs are reviewed.

中文翻译：

---

用于治疗肺部疾病的可吸入脂质体：临床发展和挑战

脂质体药物的吸入给药对于肺部疾病的治疗具有明显的优势。几种药物的可吸入脂质体目前正在针对一系列肺部适应症进行临床试验。本文综述了肺部给药的一般原理以及可吸入脂质体药物的临床开发。